Tim is a Research Associate at the Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Department of Medicine. His current research is focused on the development of antibody therapies and vaccines against bacterial infections.
For his PhD at the University of Melbourne with Professor Richard Strugnell, Tim investigated bacterial metabolism during infection and developed a novel typhoid vaccine with enhanced protection and immunogenicity. For his postdoctoral training Tim worked with Professor Filipe Cabreiro at University College London to demonstrate how gut bacteria alters the efficacy of cancer drugs. He then joined Professor Brendan Wren’s group at the London School of Hygiene of Tropical Medicine (LSHTM) to develop cost-effective vaccines against Streptococcus pneumoniae and paratyphoid. At the CITIID he is working with Dr Stephen Baker and collaborators from the International Aids Vaccine Initiative (IAVI) and the LSHTM on targeted therapies against Shigella and other enteric bacteria.